KEGG: ype:YPO2347
STRING: 187410.y1985
UPF0283 membrane protein YPO2347/y1985/YP_2134 is a membrane protein derived from Yersinia pestis, the causative bacterium of plague. The "UPF" designation indicates it belongs to an uncharacterized protein family, meaning its precise biological function remains to be fully elucidated. This protein is identified by UniProt accession number Q8ZE38 and consists of 353 amino acids in its full-length form. Most commercially available preparations are expressed as recombinant proteins in E. coli systems for research purposes .
The optimal storage conditions for recombinant UPF0283 membrane protein depend on its formulation:
For liquid formulations: Store at -20°C/-80°C for up to 6 months
For lyophilized formulations: Store at -20°C/-80°C for up to 12 months
For working aliquots: Store at 4°C for up to one week
It is critical to note that repeated freezing and thawing is not recommended as it can compromise protein integrity and functional activity . When preparing the protein for long-term storage, incorporating glycerol to a final concentration of 5-50% (with 50% being commonly recommended) helps maintain protein stability during freeze-thaw cycles .
For optimal reconstitution of lyophilized UPF0283 membrane protein, follow this methodological approach:
Briefly centrifuge the vial before opening to ensure content collection at the bottom
Reconstitute the protein in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being the standard recommendation)
Prepare aliquots of the reconstituted protein for long-term storage at -20°C/-80°C
This protocol minimizes protein degradation while maintaining stability for experimental applications . For solution stability, Tris/PBS-based buffer with 6% trehalose at pH 8.0 has been used successfully for similar UPF0283 membrane proteins .
Escherichia coli (E. coli) is the predominantly used expression system for producing recombinant UPF0283 membrane protein. Available commercial preparations utilize E. coli as their expression host, taking advantage of its:
Rapid growth kinetics and high protein yield potential
Well-established transformation and protein induction protocols
Compatibility with various affinity tags (particularly His-tags) for efficient purification
Cost-effectiveness compared to eukaryotic expression systems
The commercially available recombinant UPF0283 membrane protein preparations are typically produced with N-terminal His-tags to facilitate purification using metal affinity chromatography .
Several sophisticated experimental approaches can be employed to elucidate the structural characteristics of UPF0283 membrane protein:
X-ray Crystallography: This approach can provide high-resolution structural information, similar to methods used for other membrane protein complexes:
Requires purification to >85% homogeneity as verified by SDS-PAGE
May necessitate screening multiple crystallization conditions
Data collection parameters similar to those used for EMC complex (wavelength ~0.9-2.7 Å)
Structure determination through molecular replacement or experimental phasing methods
Computational Structure Prediction:
Protein Structure Analysis:
Table: Typical Data Collection Parameters for Membrane Protein Crystallography
| Parameter | Typical Range |
|---|---|
| X-ray wavelength | 0.9-2.7 Å |
| Resolution range | 2.2-2.7 Å |
| R-factors (Rwork/Rfree) | 20-25% |
| I/σ(I) | >1.8 |
| Completeness | >98% |
These approaches can be complemented with spectroscopic methods such as circular dichroism for secondary structure analysis and nuclear magnetic resonance for dynamics studies .
Designing experiments to identify and characterize binding partners of UPF0283 membrane protein requires a systematic approach:
Affinity Purification Coupled with Mass Spectrometry:
Yeast Two-Hybrid Screening:
Design constructs without transmembrane regions if they interfere with nuclear localization
Screen against Yersinia cDNA library
Validate positive interactions with secondary assays
Apply statistical analysis similar to experimental design studies (ANOVA, p < 0.05) to evaluate interaction significance
Experimental Design Considerations:
Implement factorial experimental design to efficiently test interaction conditions
Analyze results using statistical methods similar to EDAT analysis (F-test, p < 0.05)
Include experimental and comparison groups with appropriate sample sizes for statistical power
Data Analysis and Validation:
Apply statistical methods similar to those used in experimental design studies:
This methodological framework provides a robust approach to identifying physiologically relevant binding partners of UPF0283 membrane protein.
Crystallizing membrane proteins like UPF0283 presents several significant challenges that require specialized methodological approaches:
Protein Stability and Homogeneity Challenges:
Membrane proteins often contain flexible regions that impede crystallization
Solution: Consider implementing limited proteolysis to remove flexible segments while preserving the core structure
Apply size-exclusion chromatography to ensure monodispersity before crystallization trials
Crystallization Condition Optimization:
Data Collection and Processing Considerations:
Refinement Strategies:
Table: Comparison of Crystallization Approaches for Membrane Proteins
| Parameter | Traditional Vapor Diffusion | Lipidic Cubic Phase | Bicelle Method |
|---|---|---|---|
| Detergent requirement | High | Minimal | Moderate |
| Native-like environment | Low | High | Medium |
| Crystal packing | Type I (small contacts) | Type I/II (varied) | Type I/II (varied) |
| Typical resolution | 2.5-3.5 Å | 1.8-2.5 Å | 2.0-3.0 Å |
Successful crystallization may require specialized synchrotron facilities similar to those used for EMC complex studies (e.g., Diamond I03, I23) and phasing methods like molecular replacement or S-SAD phasing .
Optimizing experimental design for studying UPF0283 membrane protein function requires rigorous methodological approaches:
Statistical Design Considerations:
Implement a factorial experimental design similar to approaches used in educational research:
Sample Size and Power Analysis:
Factor Analysis Approach:
Control Group Design:
This methodological framework provides a statistically robust approach to studying UPF0283 membrane protein function, drawing on established experimental design principles from related scientific fields.
The ER Membrane Protein Complex (EMC) represents a critical insertion pathway for transmembrane proteins. Given that UPF0283 is also a membrane protein, several methodological approaches can be applied to investigate potential EMC-like properties:
Structural Homology Analysis:
Apply reference-free ab initio modeling using Robetta (similar to EMC8/EMC9 analysis)
Evaluate structural alignment with RMSD measurements (target <2.3 Å for significant homology)
Perform template-based modeling with known structures as references (aim for RMSD <0.6 Å)
Assess fit quality with no steric violations when docked into predicted complexes
Protein-Protein Interaction Studies:
Investigate potential interactions with components of membrane insertion machinery
Use docking simulations to predict interaction interfaces
Validate models through mutagenesis of predicted interface residues
Crystallographic Analysis:
Table: Data Collection Parameters Comparison for Membrane Protein Complexes
| Parameter | EMC Complex | Target for UPF0283 Studies |
|---|---|---|
| Resolution range | 2.2-2.7 Å | 2.0-3.0 Å |
| Completeness | >99% | >95% |
| I/σ(I) | >1.8 | >1.5 |
| CC1/2 | >80% | >75% |
| R-factors | 20-25% | <30% |
By applying these methodologies, researchers can investigate whether UPF0283 membrane protein shares functional or structural properties with known membrane protein insertion complexes .